Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 36% ± 16% | |
glutamatergic neuron | 13 studies | 74% ± 22% | |
oligodendrocyte precursor cell | 13 studies | 45% ± 16% | |
mast cell | 11 studies | 26% ± 15% | |
GABAergic neuron | 11 studies | 72% ± 20% | |
amacrine cell | 8 studies | 66% ± 23% | |
retinal cone cell | 8 studies | 78% ± 15% | |
neuron | 7 studies | 60% ± 20% | |
interneuron | 7 studies | 73% ± 26% | |
retinal ganglion cell | 7 studies | 56% ± 24% | |
retinal bipolar neuron | 5 studies | 91% ± 8% | |
OFF-bipolar cell | 5 studies | 73% ± 25% | |
ON-bipolar cell | 5 studies | 73% ± 27% | |
retina horizontal cell | 5 studies | 40% ± 26% | |
cardiac muscle cell | 5 studies | 43% ± 6% | |
endothelial cell | 4 studies | 51% ± 16% | |
granule cell | 4 studies | 70% ± 14% | |
microglial cell | 4 studies | 40% ± 12% | |
enteroendocrine cell | 4 studies | 53% ± 20% | |
oligodendrocyte | 4 studies | 35% ± 20% | |
GABAergic interneuron | 3 studies | 82% ± 5% | |
GABAergic amacrine cell | 3 studies | 86% ± 6% | |
glycinergic amacrine cell | 3 studies | 81% ± 4% | |
retinal rod cell | 3 studies | 39% ± 30% | |
rod bipolar cell | 3 studies | 95% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 5146.27 | 2557 / 2642 | 98% | 18.58 | 692 / 705 |
pancreas | 97% | 1209.01 | 318 / 328 | 76% | 5.48 | 135 / 178 |
intestine | 24% | 141.32 | 236 / 966 | 68% | 4.37 | 358 / 527 |
adrenal gland | 18% | 290.85 | 47 / 258 | 73% | 17.44 | 168 / 230 |
prostate | 37% | 397.80 | 91 / 245 | 52% | 3.77 | 261 / 502 |
heart | 78% | 1232.94 | 674 / 861 | 0% | 0 | 0 / 0 |
stomach | 10% | 53.25 | 37 / 359 | 57% | 3.41 | 162 / 286 |
skin | 8% | 46.73 | 139 / 1809 | 50% | 3.50 | 237 / 472 |
ovary | 21% | 152.95 | 38 / 180 | 22% | 0.59 | 93 / 430 |
bladder | 0% | 0 | 0 / 21 | 22% | 1.33 | 112 / 504 |
esophagus | 2% | 10.25 | 29 / 1445 | 20% | 0.92 | 36 / 183 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.35 | 4 / 29 |
breast | 7% | 40.87 | 31 / 459 | 3% | 0.34 | 33 / 1118 |
lung | 1% | 4.94 | 4 / 578 | 9% | 0.35 | 99 / 1155 |
liver | 0% | 0 | 0 / 226 | 8% | 0.39 | 32 / 406 |
uterus | 1% | 8.29 | 2 / 170 | 7% | 0.19 | 30 / 459 |
eye | 0% | 0 | 0 / 0 | 5% | 0.46 | 4 / 80 |
adipose | 2% | 16.00 | 29 / 1204 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 2% | 0.07 | 20 / 901 |
thymus | 1% | 3.28 | 4 / 653 | 1% | 0.24 | 9 / 605 |
blood vessel | 1% | 7.49 | 15 / 1335 | 0% | 0 | 0 / 0 |
spleen | 0% | 2.46 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.65 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015031 | Biological process | protein transport |
GO_0006887 | Biological process | exocytosis |
GO_0016079 | Biological process | synaptic vesicle exocytosis |
GO_0045921 | Biological process | positive regulation of exocytosis |
GO_1990504 | Biological process | dense core granule exocytosis |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098793 | Cellular component | presynapse |
GO_0005829 | Cellular component | cytosol |
GO_0099012 | Cellular component | neuronal dense core vesicle membrane |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CADPS |
Protein name | Calcium dependent secretion activator CADPS protein Calcium dependent secretion activator (Calcium-dependent secretion activator 1) Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1) |
Synonyms | CAPS CAPS1 KIAA1121 |
Description | FUNCTION: Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates catecholamine loading of DCVs. May specifically mediate the Ca(2+)-dependent exocytosis of large dense-core vesicles (DCVs) and other dense-core vesicles by acting as a PtdIns(4,5)P2-binding protein that acts at prefusion step following ATP-dependent priming and participates in DCVs-membrane fusion. However, it may also participate in small clear synaptic vesicles (SVs) exocytosis and it is unclear whether its function is related to Ca(2+) triggering (By similarity). . |
Accessions | ENST00000612439.4 ENST00000283269.13 [Q9ULU8-3] ENST00000466621.2 H7C538 ENST00000383710.9 [Q9ULU8-1] H0YFP0 ENST00000613879.4 A0A0C4DGY2 F1T0E5 ENST00000468271.5 ENST00000357948.7 [Q9ULU8-2] ENST00000473635.5 H7C4T6 ENST00000490353.2 [Q9ULU8-5] ENST00000542833.1 H7C4P2 ENST00000491424.5 Q9ULU8 A2RRN7 H7C4K9 |